Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Progesterone

Progesterone

57-83-0

DISCOVER
PHENOXYMETHYLPENICILLIN POTASSIUM CRS (260 MG)

PHENOXYMETHYLPENICILLIN POTASSIUM CRS (260 MG)

132-98-9

DISCOVER
Phentolamine mesilate - reference spectrum, Qty : n/a

Phentolamine mesilate - reference spectrum, Qty : n/a

NA

DISCOVER
PHENYLALANINE CRS (60 MG)

PHENYLALANINE CRS (60 MG)

63-91-2

DISCOVER
PHENYLBUTAZONE CRS (100 MG)

PHENYLBUTAZONE CRS (100 MG)

50-33-9

DISCOVER
PHENYLEPHRINE CRS (50 MG)

PHENYLEPHRINE CRS (50 MG)

59-42-7

DISCOVER
PHENYLEPHRINE HYDROCHLORIDE CRS (20 MG)

PHENYLEPHRINE HYDROCHLORIDE CRS (20 MG)

61-76-7

DISCOVER
PHENYLMERCURIC BORATE - REFERENCE SPECTRUM (N/A)

PHENYLMERCURIC BORATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
PHENYLPROPANOLAMINE HYDROCHLORIDE CRS - * DRUG PRECURSOR (50

PHENYLPROPANOLAMINE HYDROCHLORIDE CRS - * DRUG PRECURSOR (50

154-41-6

DISCOVER
PHENYTOIN CRS (120 MG)

PHENYTOIN CRS (120 MG)

57-41-0

DISCOVER
PHENYTOIN SODIUM CRS (250 MG)

PHENYTOIN SODIUM CRS (250 MG)

630-93-3

DISCOVER
PHTHALYLSULFATHIAZOLE CRS (100 MG)

PHTHALYLSULFATHIAZOLE CRS (100 MG)

85-73-4

DISCOVER